Epidemiological analysis of real-world immune checkpoint inhibitor-related pneumonitis in Chinese patients with lung cancer

Epidemiological analysis of real-world immune checkpoint inhibitor-related pneumonitis in Chinese patients with lung cancer

Background and purpose: In clinical studies, checkpoint inhibitor-related pneumonitis (CIP) ranks first among the causes of death in programmed cell death protein-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitor immune-related adverse events. Real-world CIP situations lack extensive population r...

Full description

Bibliographic Details
Main Author: WU Jianhui, CHU Xiangling, WANG Liqiang, LIN Xinqing, XIE Xiaohong, XIE Mengqing, ZHAO Jing, DENG Haiyi, YANG Yilin, QIU Guihuan, ZHOU Maolin, SUN Ni, LI Ru, CHEN Ying, DENG Jiaxi, ZENG Chen, PAN Bolin, QIN Yinyin, LIU Ming, SU Chunxia, ZHOU Chengzhi
Format: Article
Language:English
Published: Editorial Office of China Oncology 2022-06-01
Series:Zhongguo aizheng zazhi
Subjects:
|lung cancer|checkpoint inhibitor-related pneumonitis|immune-related adverse event|immune checkpoint inhibitor|epidemiology|real-world research
Online Access:http://www.china-oncology.com/fileup/1007-3639/PDF/1658380558758-240117235.pdf

Similar Items

Similar Items